SCHEMBL30147477

SCHEMBL30147477

O=C(O)c1cc2c(CO)cccc2[nH]1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.58
HSD17B10 Q99714 4/20 0.58
ALDH1A1 P00352 3/20 0.58
HPGD P15428 3/20 0.58
GRIN1 Q05586 2/20 0.58
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
GRIN2D O15399 1/20 0.58
GRIN3B O60391 1/20 0.58
CYP1A2 P05177 1/20 0.58
GLA P06280 1/20 0.58
GAA P10253 1/20 0.58
MAPK1 P28482 1/20 0.58
CYP2C19 P33261 1/20 0.58
AHR P35869 1/20 0.58
CHRNA7 P36544 1/20 0.58
GRIN2A Q12879 1/20 0.58
GRIN2B Q13224 1/20 0.58
GRIN2C Q14957 1/20 0.58
GRIN3A Q8TCU5 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22395238 1.00 KDM4E (0.58) KDM4EHSD17B10ALDH1A1HPGDGRIN1
SCHEMBL14208058 0.87 DAO (0.58) KDM4EHSD17B10ALDH1A1HPGDGRIN1
SCHEMBL2003603 0.83 SRD5A2 (0.60) KDM4EHSD17B10ALDH1A1HPGDGRIN1
SCHEMBL2008256 0.81 SRD5A2 (0.59) KDM4EHSD17B10ALDH1A1HPGDGRIN1
SCHEMBL2007157 0.80 HTR6 (0.53) KDM4EHSD17B10ALDH1A1HPGDGRIN1
SCHEMBL2007295 0.79 KDM4E (0.50) KDM4EHSD17B10ALDH1A1HPGDGRIN1
SCHEMBL2004308 0.79 SRD5A2 (0.56) KDM4EHSD17B10ALDH1A1HPGDGRIN1
SCHEMBL2008852 0.79 SRD5A2 (0.56) KDM4EHSD17B10ALDH1A1HPGDGRIN1
SCHEMBL2006209 0.79 SRD5A2 (0.60) KDM4EHSD17B10ALDH1A1HPGDGRIN1
SCHEMBL2003488 0.79 KDM4E (0.50) KDM4EHSD17B10ALDH1A1HPGDGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115551864-A Substituted tricyclic amides, analogs thereof, and methods of using the same 爱彼特生物制药公司 2022-12-30 CN disclosed